Pell ResearchProfessional, Scientific, and Technical Services > Research & Development in Biotechnology

Research & Development in Biotechnology Industry - Market Research, Company Data, and Financial Statistics

Research & Development in Biotechnology - Market Size and Industry Forecast

The 2021 Research and Development in Biotechnology Industry Report contains historical and forecasted statistics used by leading private equity firms and consultants. Market sizes from 2016 to 2026 reflect industry trends and growth patterns. Market size revenues include both public and private companies in the research & development in biotechnology industry.

Market Size (Total Revenue)

% Growth Rate
Number of Companies
Total Employees
Average Revenue per Company
Average Employees per Company
Source: U.S. government financial data.

Industry Revenue ($ Billions)

Industry Revenue Forecast
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022

Advanced econometric models forecast five years of industry growth based on short- and long-term trend analysis. Market size includes revenue generated from all products and services sold within the industry.

Research & Development in Biotechnology - Geographic Breakdown by U.S. State

Market size by state reveals local opportunity through the number of companies located in the region. Each state's growth rate is affected by regional economic conditions. Data by state can be used to pinpoint profitable and nonprofitable locations for Research & Development in Biotechnology companies in the United States.

Research & Development in Biotechnology Revenue by State

Market Size by State

Distribution by Company Size

Company SizeAll IndustriesResearch & Development in Biotechnology
Small Business (< 5 Employees)

Small Business (5 - 20)
Midsized Business (20 - 100)
Large Business (100 - 500)
Enterprise (> 500)

Research & Development in Biotechnology - Income Statement (Average Financial Metrics)

Financial statement analysis determines averages for the following industry forces:
The report includes a traditional income statement from an "average" company (both public and private companies included).

Industry AveragePercent of Sales
Total Revenue

Operating Revenue
Cost of Goods Sold (COGS)
Gross Profit
Operating Expenses
Operating Income
Non-Operating Income
Earnings Before Interest and Taxes (EBIT)
Interest Expense
Earnings Before Taxes
Income Tax
Net Profit

Average Income Statement

Average Income Statement

Cost of Goods Sold

Salaries, Wages, and Benefits



Depreciation and Amortization

Officer Compensation

Net Income

Research & Development in Biotechnology - Financial Ratio Analysis

Financial ratios allow a company's performance to be compared against that of its peers.

Financial RatioIndustry Average
Profitability Ratios

Profit Margin
Liquidity Ratios
Current Ratio
Quick Ratio
Activity Ratios
Average Collection Period
Asset Turnover Ratio
Receivables Turnover Ratio
Inventory Conversion Ratio

Research & Development in Biotechnology - Product Mix

Product DescriptionDescriptionRevenue
($ Millions)
Industry total

Licensing of rights to use intellectual property
Licensing of rights use intellectual prop - protected industrial
Basic & applied research in biotechnology
Development services for goods
All other operating receipts
Contributions, gifts, & grants - government
Licensing of rights to intellectual prop - protected by copyright
Contributions, gifts, & grants - private
Outright sale of original works of intellectual property

Research & Development in Biotechnology - Compensation and Salary Surveys

TitlePercent of WorkforceBottom QuartileAverage (Median) SalaryUpper Quartile
Management Occupations14%

Chief Executives0%
General and Operations Managers2%
Other Management Occupations6%
Business and Financial Operations Occupations10%
Business Operations Specialists8%
Computer and Mathematical Occupations12%
Computer Occupations11%
Software Developers and Programmers5%
Architecture and Engineering Occupations17%
Life, Physical, and Social Science Occupations25%
Life Scientists12%
Medical Scientists7%
Medical Scientists, Except Epidemiologists7%
Life, Physical, and Social Science Technicians7%
Office and Administrative Support Occupations9%

Government Contracts

In the past, the federal government spent an annual total of $1,863,368,936 on the research & development in biotechnology industry. It has awarded 2,916 contracts to 713 companies, with an average value of $2,613,421 per company.

Research & Development in Biotechnology and Adjacent Industries - Top Companies

($ Millions)

Research & Development in Biotechnology Industry Report
GeographyUnited States  
Publication DateJuly 2021
Report FormatPDF Download  

Related Market Research Reports

Scientific Research & Development Services
Research & Development in the Physical, Engineering & Life Sciences
Research & Development in Biotechnology
Research & Development in Nanotechnology
Research & Development in the Social Sciences & Humanities